Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karen Fusaro
Sponsor GmbH
Study Director - Keith Kaye
Wayne State University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Buenos Aires, Argentina
- Facility name not stated
Córdoba, Argentina
- Facility name not stated
La Plata, Argentina
- Facility name not stated
Mendoza, Argentina
- Facility name not stated
São José do Rio Preto, São Paulo, Brazil
- Facility name not stated
Belo Horizonte, Brazil
- Facility name not stated
Curitiba, Brazil
- Facility name not stated
Porto Alegre, Brazil
- Facility name not stated
São Paulo, Brazil
- Facility name not stated
São Paulo, Brazil
- Facility name not stated
São Paulo, Brazil
- Facility name not stated
Barranquilla, Colombia
- Facility name not stated
Bogotá, Colombia
- Facility name not stated
Medellín, Colombia
- Facility name not stated
Athens, Greece
- Facility name not stated
Athens, Greece
- Facility name not stated
Athens, Greece
- Facility name not stated
Thessaloniki, Greece
- Facility name not stated
Haifa, Israel
- Facility name not stated
Petah Tikva, Israel
- Facility name not stated
Ramat Gan, Israel
- Facility name not stated
Tel Aviv, Israel
- Facility name not stated
Bologna, Italy
- Facility name not stated
Florence, Italy
- Facility name not stated
Genova, Italy
- Facility name not stated
Pisa, Italy
- Facility name not stated
Rome, Italy
- Facility name not stated
Udine, Italy
- Facility name not stated
Manchester, United Kingdom
- Facility name not stated
Manchester, United Kingdom
- Facility name not stated
Hartford, Connecticut, United States
- Facility name not stated
Tampa, Florida, United States
- Facility name not stated
Augusta, Georgia, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Evanston, Illinois, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
Detroit, Michigan, United States
- Facility name not stated
Royal Oak, Michigan, United States
- Facility name not stated
New Brunswick, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2014
- Primary completion
- 21 Jul 2017
- Completion
- 21 Jul 2017
- Last update posted
- 4 Mar 2019
- Registered enrollment
- 77
- Registry id
- NCT02168946
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.